共 50 条
Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function
被引:23
|作者:
Bae, Sunjae
[1
,2
,3
]
Wang, Jacqueline M. Garonzik
[3
]
Massie, Allan B.
[1
,3
]
Jackson, Kyle R.
[3
]
McAdams-DeMarco, Mara A.
[1
,3
]
Brennan, Daniel C.
[4
]
Lentine, Krista L.
[5
]
Coresh, Josef
[1
,2
,4
]
Segev, Dorry L.
[1
,3
]
机构:
[1] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] St Louis Univ, Ctr Abdominal Transplantat, St Louis, MO 63103 USA
来源:
关键词:
RENAL-TRANSPLANTATION;
ACUTE REJECTION;
CORTICOSTEROID AVOIDANCE;
MYCOPHENOLATE-MOFETIL;
RISK;
IMMUNOSUPPRESSION;
REGIMEN;
TRIAL;
MULTICENTER;
PREDNISONE;
D O I:
10.1681/ASN.2019040416
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Background Early steroid withdrawal (ESW) is associated with acceptable outcomes in kidney transplant (KT) recipients. Recipients with delayed graft function (DGF), however, often have a suboptimal allograft milieu, which may alter the risk/benefit equation for ESW. This may contribute to varying practices across transplant centers. Methods Using the Scientific Registry of Transplant Recipients, we studied 110,019 adult deceased-donor KT recipients between 2005 and 2017. We characterized the association of DGF with the use of ESW versus continued steroid maintenance across KT centers, and quantified the association of ESW with acute rejection, graft failure, and mortality using multivariable logistic and Cox regression with DGF-ESW interaction terms. Results Overall 29.2% of KT recipients underwent ESW. Recipients with DGF had lower odds of ESW (aOR=( 0.60)0.67(0.75)). The strength of this association varied across 261 KT centers, with center-specific aOR of <0.5 at 31 (11.9%) and >1.0 at 22 (8.4%) centers. ESW was associated with benefits and harms among recipients with immediate graft function (IGF), but only with harms among recipients with DGF. ESW was associated with increased acute rejection (aOR= (1.09)1.16(1.23)), slightly increased graft failure (aHR= (1.01)1.06(1)(.1)(2)), but decreased mortality (aHR= (0.86)0.89(0.93)) among recipients with IGF. Among recipients with DGF, ESW was associated with a similar increase in rejection (aOR=1.12; 95% CI, 1.02 to 1.23), a more pronounced increase in graft failure (aHR=1.16; 95% CI, 1.08 to 1.26), and no improvement in mortality (aHR=1.00; 95% CI, 0.94 to 1.07). DGF-ESW interaction was statistically significant for graft failure (P=0.04) and mortality (P=0.003), but not for rejection (P=0.6). Conclusions KT centers in the United States use ESW inconsistently in recipients with DGF. Our findings suggest ESW may lead to worse KT outcomes in recipients with DGF.
引用
收藏
页码:175 / 185
页数:11
相关论文